First-Generation Cephalosporin — Obstetric Antibiotic
Pregnancy: Safe throughout pregnancy
Cefalexin (UTI / GBS Prophylaxis in Pregnancy)
Brand names: Ceporex, Keflex
Adult dose
Dose: 500 mg four times daily for 7 days (UTI treatment); 500 mg four times daily intrapartum (GBS — if penicillin allergic, low risk)
Route: Oral
Frequency: Four times daily
Max: 4 g/day
UTI in pregnancy: 7-day course recommended (longer than non-pregnant). GBS carrier with low-risk penicillin allergy: cefalexin oral for low-risk labours; benzylpenicillin IV preferred intrapartum for GBS prophylaxis
Paediatric dose
Dose: Not applicable in this obstetric context N/A/kg
Route: Oral
Frequency: N/A
Max: N/A
Maternal medication
Dose adjustments
Renal
Reduce frequency in severe renal impairment
Hepatic
No adjustment required
Paediatric weight-based calculator
Maternal medication
Clinical pearls
- Preferred antibiotic for UTI in pregnancy — safe in all trimesters; nitrofurantoin avoided at term (neonatal haemolysis risk), trimethoprim avoided in first trimester (folate antagonist)
- GBS (Group B Streptococcus): RCOG advises benzylpenicillin IV intrapartum as first-line; cefalexin oral is NOT adequate intrapartum GBS prophylaxis for high-risk labours — only IV antibiotics achieve sufficient fetal blood levels
- 7-day course for UTI in pregnancy: longer than non-pregnant (3-5 days) due to physiological changes (ureteric dilatation, increased renal blood flow, glycosuria) increasing risk of ascending infection and pyelonephritis
- Test of cure: urine culture 7 days after completing treatment mandatory in pregnancy — asymptomatic bacteriuria recurrence is common
- Penicillin allergy assessment: document exact reaction — if anaphylaxis/urticaria, avoid cephalosporins; if rash only (non-IgE-mediated), cefalexin generally safe
Contraindications
- Hypersensitivity to cephalosporins
- Severe penicillin allergy (10% cross-reactivity — use alternative)
Side effects
- GI upset
- Candidal superinfection
- Hypersensitivity reactions
Interactions
- Warfarin (enhanced anticoagulant effect)
Monitoring
- Urine culture test of cure (7 days after treatment)
- Symptoms resolution
Reference: BNFc; BNF 90; RCOG Green-top 36 (Group B Streptococcal Disease 2017); NICE NG112 (UTI in Adults). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Caprini Score for VTE Risk (2005) · VTE Risk
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Caprini VTE Risk Assessment · Venous Thromboembolism
- Khorana Score for VTE in Cancer · VTE Risk
- IMPROVE-DD VTE Risk Score · VTE Risk
- Padua Prediction Score for VTE Risk in Medical Inpatients · Venous Thromboembolism